Improving pharmacological rescue of p53 function: RITA targets mutant p53

Cell Cycle

Volumn 9, Issue 11, 2010, Pages 2059-2062

  Girardini, Javier E ^a   Del Sal, Giannino ^b  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN P53; PROTEIN P63; PROTEIN P73; PUMA PROTEIN; RITA; SMAD2 PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; COMPLEX FORMATION; DNA BINDING; DNA DAMAGE; DRUG TARGETING; GENE EXPRESSION; GENE INDUCTION; HUMAN; PROTEIN CONFORMATION; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SHORT SURVEY;

EID: 77953592090     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.11.11859     Document Type: Short Survey

References (9)

1. Soussi T, et al. Cancer Cell 2007; 12: 303-312.
2. Selivanova G, et al. Oncogene 2007; 26: 2243-2254.
3. Vassilev LT, et al. Science 2004; 303: 844-848.
4. Issaeva N, et al. Nat Med 2004; 10: 1321-1328.
5. Adorno M, et al. Cell 2009; 137: 87-98.
6. Gaiddon C, et al. Mol Cell Biol 2001; 21: 1874-1887.
7. Yang J, et al. Mol Cell Biol 2009; 29: 2243-2253.
8. Brosh R, et al. Nat Rev Cancer 2009; 9: 701-713.
9. Lim LY, et al. Brithish J Cancer 2009; 1-7.